OTCMKTS:LCDXLucid Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Lucid Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.57 +0.01 (+1.79 %) (As of 08/10/2020 03:05 PM ET) Add Compare Share Today's Range$0.56Now: $0.57▼$0.6050-Day Range$0.46MA: $0.53▼$0.8252-Week Range$0.25Now: $0.57▼$1.10Volume63,158 shsAverage Volume54,896 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesShort InterestSocial Media Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Lucid. Previous Next 2.5 Community Rank Outperform VotesLucid has received 90 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLucid has received 89 “underperform” votes. (Add your “underperform” vote.)Community SentimentLucid has received 50.28% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Lucid and other stocks. Vote “Outperform” if you believe LCDX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LCDX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLucid does not currently pay a dividend.Dividend GrowthLucid does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Lucid insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:LCDX Previous Symbol CUSIPN/A CIKN/A Webwww.caliberid.com Phone+1-585-2399800Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees28 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.57 +0.01 (+1.79 %) (As of 08/10/2020 03:05 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive LCDX News and Ratings via Email Sign-up to receive the latest news and ratings for LCDX and its competitors with MarketBeat's FREE daily newsletter. Lucid (OTCMKTS:LCDX) Frequently Asked Questions How has Lucid's stock been impacted by COVID-19 (Coronavirus)? Lucid's stock was trading at $0.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LCDX stock has decreased by 21.9% and is now trading at $0.57. View which stocks have been most impacted by Coronavirus. Has Lucid been receiving favorable news coverage? Press coverage about LCDX stock has been trending very positive on Monday, according to InfoTrie. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Lucid earned a media sentiment score of 3.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Lucid. Who are some of Lucid's key competitors? Some companies that are related to Lucid include Smith & Nephew (SN), Corindus Vascular Robotics (CVRS), Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), InspireMD (NSPR), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS). View all competitors. What other stocks do shareholders of Lucid own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lucid investors own include Etsy (ETSY), J C Penney (JCP), Benefitfocus (BNFT), Aphria (APHA), Arista Networks (ANET), Amgen (AMGN), Advanced Micro Devices (AMD), Akers Biosciences (AKER), AdvisorShares Vice ETF (ACT) and Accenture (ACN). Who are Lucid's key executives? Lucid's management team includes the following people: Mr. William J. Shea, Exec. Chairman (Age 71)Mr. L. Michael Hone, CEO & Director (Age 69)Mr. William J. Fox, CTO & VP of Technology Operations (Age 53)Ms. Karen Howe, Chief Financial OfficerMr. Robert T. Kelley, VP of Sales and Marketing What is Lucid's stock symbol? Lucid trades on the OTCMKTS under the ticker symbol "LCDX." How do I buy shares of Lucid? Shares of LCDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Lucid's stock price today? One share of LCDX stock can currently be purchased for approximately $0.57. What is Lucid's official website? The official website for Lucid is www.caliberid.com. How can I contact Lucid? Lucid's mailing address is 100 Burtt Rd Ste 203, ANDOVER, MA 01810-5920, United States. The company can be reached via phone at +1-585-2399800. This page was last updated on 8/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
